本页面由Tiger Trade Technology Pte. Ltd.提供服务

Alterity Therapeutics Limited

3.60
+0.05001.41%
盘后3.600.00000.00%16:22 EDT
成交量:2,291.00
成交额:8,055.23
市值:6,525.25万
市盈率:-6.06
高:3.60
开:3.47
低:3.47
收:3.55
52周最高:7.00
52周最低:2.52
股本:1,812.57万
流通股本:1,245.82万
量比:0.22
换手率:0.02%
股息:- -
股息率:- -
每股收益(TTM):-0.5940
每股收益(LYR):-0.7470
净资产收益率:-47.02%
总资产收益率:-32.54%
市净率:1.72
市盈率(LYR):-4.82

数据加载中...

2025/08/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/09/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/07/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/07/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership